| Autor: |
Ceulemans, Michael, Cuppers, B. (Benedikte), de Vries, L. (Loes), Allegaert, K., Duvekot, J. J. (Hans), van Puijenbroek, E. P. |
| Přispěvatelé: |
Pharmacy, Obstetrics & Gynecology |
| Rok vydání: |
2020 |
| Zdroj: |
Nederlands Tijdschrift voor Geneeskunde, 164(28):D5036. Bohn Stafleu van Loghum |
| ISSN: |
0028-2162 |
| Popis: |
SARS-CoV-2 has rapidly spread worldwide since December 2019. Obviously, pregnant and lactating women will also be infected with SARS-CoV-2. Pregnant women, however, are a risk population for developing severe respiratory infections. Currently, the knowledge on potential risks and consequences of COVID-19 during pregnancy and lactation is limited. Available data show that pregnant women suffer from similar symptoms compared to non-pregnant patients. There is no evidence as yet that COVID-19 has a more serious course during pregnancy. Although pregnant women might suffer from a wide variety of symptoms, most of them are asymptomatic. Maternal SARS-CoV-2 infection might lead to adverse neonatal outcomes, such as prematurity or respiratory symptoms. There is currently no conclusive evidence of absence of intrauterine transmission of the virus; the virus has not been detected in breastmilk in most studies, although passage into breastmilk cannot be completely excluded. ispartof: Nederlands Tijdschrift voor Geneeskunde vol:164 ispartof: location:Netherlands status: published |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
